159 results
D
TNFA
TNF Pharmaceuticals Inc.
31 May 24
$15.15 mm in equity / options / securities to be acquired, sold $15.15 mm, 5 investors
8:00am
materials under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
D
TNFA
TNF Pharmaceuticals Inc.
31 May 24
$26.85 mm in equity / options / securities to be acquired, sold $26.85 mm, 4 investors
8:00am
materials under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
8-K
EX-10.4
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
, willful misconduct or fraud or any untrue statement or omission contained in such prospectus or other document based upon written information furnished
8-K
EX-10.3
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
, or expense arises out of or is based upon such Indemnified Person’s gross negligence, willful misconduct or fraud or any untrue statement or omission
8-K
EX-3.2
j10gzsqk9t
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm